84 related articles for article (PubMed ID: 4412044)
21. Prolongation of anti-inflammatory effect of prednisolone acetate. Influence of formulation in high-viscosity gel.
Kupferman A; Ryan WJ; Leibowitz HM
Arch Ophthalmol; 1981 Nov; 99(11):2028-9. PubMed ID: 7295153
[TBL] [Abstract][Full Text] [Related]
22. Topical diclofenac treatment prior to excimer laser photorefractive keratectomy in rabbits.
Szerenyi K; Wang XW; Lee M; McDonnell PJ
Refract Corneal Surg; 1993; 9(6):437-42. PubMed ID: 8117642
[TBL] [Abstract][Full Text] [Related]
23. Investigations on the activity of p-chlorophenylamide of 3-methyl-5-benzoylaminoisothiazole-4-carboxylic acid (ITCL) in the experimental keratitis.
Giełdanowski J
Arch Immunol Ther Exp (Warsz); 1983; 31(5):621-9. PubMed ID: 6326706
[TBL] [Abstract][Full Text] [Related]
24. Management of inflammation in the cornea and conjunctiva.
Leibowitz HM
Ophthalmology; 1980 Aug; 87(8):753-8. PubMed ID: 7443202
[TBL] [Abstract][Full Text] [Related]
25. Antiinflammatory activity of two novel derivatives of prednisolone.
Lee HJ; Trottier R
Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):611-4. PubMed ID: 6892963
[TBL] [Abstract][Full Text] [Related]
26. The effect of steroidal and nonsteroidal anti-inflammatory agents on corneal re-epithelialization.
Srinivasan BD; Kulkarni PS
Invest Ophthalmol Vis Sci; 1981 May; 20(5):688-91. PubMed ID: 7216684
[TBL] [Abstract][Full Text] [Related]
27. Rabbit Streptococcus pneumoniae keratitis model and topical therapy.
Guzek JP; Cline DJ; Row PK; Wessels IF; Beeve S; Ispirescu S; Aprecio RM; Kettering JD; Gano DL; Nelson GM
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2012-7. PubMed ID: 9761279
[TBL] [Abstract][Full Text] [Related]
28. Comparative anti-inflammatory efficacy of topical corticosteroids with low glaucoma-inducing potential.
Leibowitz HM; Ryan WJ; Kupferman A
Arch Ophthalmol; 1992 Jan; 110(1):118-20. PubMed ID: 1731703
[TBL] [Abstract][Full Text] [Related]
29. [Pannus].
Heijn A
Tijdschr Diergeneeskd; 1992 Dec; 117(23):713. PubMed ID: 1462347
[No Abstract] [Full Text] [Related]
30. The suppression of acute corneal inflammation by Bredinin.
Carter JM; Gebhardt BM; Kissling GE; Kaufman HE
J Ocul Pharmacol; 1987; 3(3):191-7. PubMed ID: 3503914
[TBL] [Abstract][Full Text] [Related]
31. Topical administration of leukotriene antagonists in immunogenic keratitis.
van Delft JL; van Haeringen NJ; Barthen ER; van Best JA; Blackham A
Ophthalmic Res; 1991; 23(6):330-4. PubMed ID: 1803314
[TBL] [Abstract][Full Text] [Related]
32. [Subscleral administration of hydrocortisone and prednisolone in certain keratites].
Opalev LM
Oftalmol Zh; 1973; 28(3):178-80. PubMed ID: 4720215
[No Abstract] [Full Text] [Related]
33. [The effect of topical steroid medication on experimental candida keratitis].
Isobe Y
Nippon Ganka Gakkai Zasshi; 1991 Jan; 95(1):45-51. PubMed ID: 2042529
[TBL] [Abstract][Full Text] [Related]
34. [Inflammation cells in the cornea after injection of heterogenous protein].
Pau H; Höhfeld K
Ber Zusammenkunft Dtsch Ophthalmol Ges; 1970; 70():28-32. PubMed ID: 5537485
[No Abstract] [Full Text] [Related]
35. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ
Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389
[TBL] [Abstract][Full Text] [Related]
36. Calotropis procera -induced keratitis.
Pandey N; Chandrakar AK; Garg ML; Patel SS
Indian J Ophthalmol; 2009; 57(1):58-60. PubMed ID: 19075415
[TBL] [Abstract][Full Text] [Related]
37. Effect of hybrid peptides of cecropin A and melittin in an experimental model of bacterial keratitis.
Nos-Barbera S; Portoles M; Morilla A; Ubach J; Andreu D; Paterson CA
Cornea; 1997 Jan; 16(1):101-6. PubMed ID: 8985641
[TBL] [Abstract][Full Text] [Related]
38. Management of suppurative keratitis.
Coster DJ
Trans Ophthalmol Soc N Z; 1982; 34():59-63. PubMed ID: 6953696
[No Abstract] [Full Text] [Related]
39. [Mental rationale for local use of angiotensin-converting enzyme in the treatment of inflammatory processes in the eye].
Chesnokova NB; Kost OA; Nikol'skaia II; Beznos OV; Binevskiĭ PV; Stoliarova EP; Pavlenko TA
Vestn Oftalmol; 2008; 124(2):16-9. PubMed ID: 18488463
[TBL] [Abstract][Full Text] [Related]
40. [Experimental studies on the corneal toxicity of antiviral agents].
Hara J
Nippon Ganka Gakkai Zasshi; 1971 Jul; 75(7):1399-403. PubMed ID: 5107193
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
